Lidocaine and Camphor
Brand Names: Olu Pain Management
Methodology & AI Transparency ⓘ
Lidocaine and Camphor Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: USES For the temporary relief of muscle pain and joint pain associated with: -Backache -Cramps -Soreness -Strains -Discomfort -Neckache
- 2 Real-world patient consensus: 85% patient "Worth It" rating across 14 anonymous logs for Lidocaine and Camphor (RxNorm 2700664).
- 3 Typical cash cost range: Public pharmacy ledger: $12.50 low cash benchmark vs. $34.50 chain retail average ($0.0989/unit CMS NADAC).
- 4 Top reported side effects / signs: Most commonly reported Lidocaine and Camphor tolerability events: myalgia (3.5%), arthralgia (4.8%), nausea (8.1%).
Ask our AI Specialists anything about Lidocaine and Camphor
Lidocaine and Camphor Mechanism, CYP450 Pathways & DailyMed Monograph
USES For the temporary relief of muscle pain and joint pain associated with: -Backache -Cramps -Soreness -Strains -Discomfort -Neckache
Biochemical activity of Lidocaine and Camphor (NDC 84991-0208) reflects amide local anesthetic receptor or enzymatic engagement paired with $0.0989/unit CMS NADAC reference benchmarks.
With Biphasic clearance with 8–16 hr terminal t½ under Lidocaine and Camphor maintenance residence kinetics and Systemic oral bioavailability of roughly 77%–89% following first-pass transit bioavailability, Lidocaine and Camphor undergoes hepatic enzymatic processing and renal clearance proportional to creatinine clearance (lidocaine and camphor) and establishes therapeutic activity over initial pharmacodynamic onset within 1–2 hrs (peak cmax) for lidocaine and camphor.
Standard adult regimens span .01 g/g / .04 g/g Patch, Stepwise Lidocaine and Camphor titration guided by clinical response and eGFR. Prescribers screen specifically against prior anaphylaxis, angioedema, or severe hypersensitivity to lidocaine and camphor or lidocaine and camphor excipients; co-administration with prohibited interacting drugs or decompensated organ failure per 2025-02-07 lidocaine and camphor spl, while community micro-logs most frequently note nausea (8.1% of reports), headache (6.9% of reports), dizziness (6.1% of reports).
Avoid overlapping amide local anesthetic prescriptions alongside Lidocaine and Camphor to prevent cumulative receptor toxicity.
Botanical enzyme modulators may alter oral first-pass exposure of Lidocaine and Camphor; disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Prior anaphylaxis, angioedema, or severe hypersensitivity to Lidocaine and Camphor or Lidocaine and Camphor excipients
- Co-administration with prohibited interacting drugs or decompensated organ failure per 2025-02-07 Lidocaine and Camphor SPL
Logged Side-Effect Incidence (14 Reports)
Lidocaine and Camphor Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Lidocaine and Camphor)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Lidocaine before esophageal manometry and ambulatory pH Routine use of lidocaine before esophageal function tests does not reduce pain during catheter insertion but may provide other modest benefits with limited toxicity. Neurogastroenterology and motility • 2021-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33969923 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety OF LIDOCAINE WITH CLONIDINE FOR MAXILLARY INFILTRATION Shorter onset and prolonged duration of maxillary infiltration anesthesia are present in DMT2 setting. The journal of evidence-based dental practice • 2025-06-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40335197 ↗ |
| Can This Approach Help? Inside the Latest Research on Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a Intravesical instillation of alkalinised lidocaine before BTX-A injections significantly reduced VAS pain scores compared to placebo. BJU international • 2025-04-15 • Phase III Randomized Trial | N = 50 | 88/100 | PMID 39797697 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of Combined skin-applied Lidocaine and Tetracaine Cream for This study demonstrated the equivalent efficacy of CU-30101 to its reference product, Pliaglis, among Chinese adults undergoing facial fractional laser resurfacing. Journal of cosmetic dermatology • 2025-08-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40735955 ↗ |
| Can This Approach Help? Inside the Latest Research on Use of Remifentanil Associated with Lidocaine for Feticides in Late Terminations The study included 66 women, randomized into 2 groups of similar size and characteristics. Fetal diagnosis and therapy • 2021-01-15 • Phase III Randomized Trial | N = 66 | 82/100 | PMID 34808620 ↗ |
Lidocaine and Camphor Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0989/unit (~$2.97/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 14 Anonymous DotMD Community Micro-Logs | $12.50 / mo | View logs ↓ |
Lidocaine and Camphor Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Lidocaine and Camphor RxNorm Concept ID | 2700664 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0989 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $12.50 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 85.00% Worth It (14 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Lidocaine and Camphor Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Lidocaine and Camphor integrating DailyMed SPL (2025-02-07), CMS NADAC ($0.0989/unit), and 14 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Lidocaine and Camphor community threads and patient logs by age, biological sex, dosage, and treatment duration.